A blended genome and exome sequencing method captures genetic variation in an unbiased, high-quality, and cost-effective manner
Boltz, T. A.; Chu, B. B.; Liao, C.; Sealock, J. M.; Ye, R.; Majara, L.; Fu, J. M.; Service, S.; Zhan, L.; Medland, S. E.; Chapman, S. B.; Rubinacci, S.; DeFelice, M.; Grimsby, J. L.; Abebe, T.; Alemayehu, M.; Ashaba, F. K.; Atkinson, E. G.; Bigdeli, T.; Bradway, A. B.; Brand, H.; Chibnik, L. B.; Fekadu, A.; Gatzen, M.; Gelaye, B.; Gichuru, S.; Gildea, M. L.; Hill, T. C.; Huang, H.; Hubbard, K. M.; Injera, W. E.; James, R.; Joloba, M.; Kachulis, C.; Kalmbach, P. R.; Kamulegeya, R.; Kigen, G.; Kim, S.; Koen, N.; Kwobah, E. K.; Kyebuzibwa, J.; Lee, S.; Lennon, N. J.; Lind, P. A.; Lopera-Maya, E.
Show abstract
We deployed the Blended Genome Exome (BGE), a DNA library blending approach that generates low pass whole genome (1-4x mean depth) and deep whole exome (30-40x mean depth) data in a single sequencing run. This technology is cost-effective, empowers most genomic discoveries possible with deep whole genome sequencing, and provides an unbiased method to capture the diversity of common SNP variation across the globe. To evaluate this new technology at scale, we applied BGE to sequence >53,000 samples from the Populations Underrepresented in Mental Illness Associations Studies (PUMAS) Project, which included participants across African, African American, and Latin American populations. We evaluated the accuracy of BGE imputed genotypes against raw genotype calls from the Illumina Global Screening Array. All PUMAS cohorts had R2 concordance [≥]95% among SNPs with MAF[≥]1%, and never fell below [≥]90% R2 for SNPs with MAF<1%. Furthermore, concordance rates among local ancestries within two recently admixed cohorts were consistent among SNPs with MAF[≥]1%, with only minor deviations in SNPs with MAF<1%. We also benchmarked the discovery capacity of BGE to access protein-coding copy number variants (CNVs) against deep whole genome data, finding that deletions and duplications spanning at least 3 exons had a positive predicted value of [~]90%. Our results demonstrate BGE scalability and efficacy in capturing SNPs, indels, and CNVs in the human genome at 28% of the cost of deep whole-genome sequencing. BGE is poised to enhance access to genomic testing and empower genomic discoveries, particularly in underrepresented populations.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A survey of rare epigenetic variation in 23,116 human genomes identifies disease-relevant epivariations and novel CGG expansions 96%
- Summix: A method for detecting and adjusting for population structure in genetic summary data 96%
- A phenome-wide association study identifies effects of copy number variation of VNTRs and multicopy genes on multiple human traits 96%
Similar papers in this journal
- Functional annotation of rare structural variation in the human brain 96%
- Diverse ancestral representation improves genetic intolerance metrics 96%
- Diagnostic Utility of Genome-wide DNA Methylation Analysis in Genetically Unsolved Developmental and Epileptic Encephalopathies and Refinement of a CHD2 Episignature 96%
Similar papers in this journal
- Omics-informed CNV calls reduce false positive rate and improve power for CNV-trait associations 96%
- Long-read genome sequencing for the diagnosis of neurodevelopmental disorders 95%
- Multivariate adaptive shrinkage improves cross-population transcriptome prediction for transcriptome-wide association studies in underrepresented populations 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.